arXiv (All)
open access
Challenges and Opportunities in Statistical Analyses and Designs for Neuroscience Clinical Trials
Drug development is a complex, costly, and high-risk process, with neuroscience representing one of the most challenging therapeutic areas due to the complexity of neurodegenerative and neuropsychiatric disorders. Neuroscience clinical trials face unique barriers, making the adoption of innovative s
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Disease-level drug approval forecasting from trial-agnostic public data#1324614
- Clinical trials in neurosciences: Need for standards for innovation on clinical outcomes.#280842
- Rational exploration/exploitation strategies for drug discovery in low data regimes#261952
- Daring to leave the laboratory: Why operational neuroscience requires a different research strategy#1081537
- Daring to leave the laboratory: Why operational neuroscience requires a different research strategy#1081441
Record · ID 1355822
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive